CLL Academy – IACH Journal Club – Zanubrutinib and Venetoclax for Patients With Treatment-Na¨ ıve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/TP53 Mutation: SEQUOIA Arm D Results – Tuesday, July 8, 2025

Current Status

Not Enrolled

Price

Free

Get Started

Dr. Mohamed Kharfan Dabaja, Dr. Mazyar Shadman, Dr. Talha Munir, Prof. Mohamad Mohty

Course Content

CLL Academy – Journal Club
Final Quiz